chr6:29794744:> Detail (hg19)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr6:29,794,744-29,798,902 |
| hg38 | chr6:29,826,967-29,831,125 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.003 | squamous cell carcinoma | NA | LHGDN | Detail | |
| 0.005 | Carcinoma, Transitional Cell | NA | GAD,LHGDN | Detail | |
| 0.005 | Cardiomyopathy, Dilated | NA | GAD,LHGDN | Detail | |
| <0.001 | hepatitis B | Four SNPs (rs17875380, rs41557518, rs114465251, and rs115492845) were associated... | BeFree | 22015712 | Detail |
| 0.001 | liver carcinoma | Four SNPs (rs17875380, rs41557518, rs114465251, and rs115492845) were associated... | BeFree | 22015712 | Detail |
| 0.003 | celiac disease | HLA-G and susceptibility to develop celiac disease. | BeFree,GAD | 25500250 | Detail |
| 0.001 | Malignant tumor of cervix | NA | BeFree | Detail | |
| 0.002 | Uterine Cervical Neoplasm | NA | GAD | Detail | |
| 0.002 | intrahepatic cholestasis | NA | GAD | Detail | |
| 0.002 | chorioamnionitis | NA | GAD | Detail | |
| 0.002 | choriocarcinoma | NA | BeFree | Detail | |
| <0.001 | Congenital chromosomal disease | If a fetus were aneuploid, attributing causation to a HLA-G 5'-URR SNP would be ... | BeFree | 25457193 | Detail |
| 0.003 | ulcerative colitis | NA | BeFree,LHGDN | Detail | |
| 0.003 | Colonic Neoplasms | NA | LHGDN | Detail | |
| 0.001 | colorectal carcinoma | Kaplan-Meier analysis results showed that the expression levels of HLA-G or HLA-... | BeFree | 25461612 | Detail |
| 0.003 | Colorectal Neoplasms | NA | LHGDN | Detail | |
| 0.002 | coronary aneurysm | NA | GAD | Detail | |
| 0.003 | Crohn Disease | Association between sHLA-G and HLA-G 14-bp deletion/insertion polymorphism in Cr... | BeFree,LHGDN | 25577194 | Detail |
| 0.003 | Cytomegalovirus Infections | NA | BeFree,GAD | Detail | |
| 0.003 | Diabetes Mellitus, Insulin-Dependent | NA | BeFree,GAD | Detail | |
| 0.003 | eclampsia | NA | BeFree | Detail | |
| 0.006 | endometriosis | NA | BeFree,LHGDN | Detail | |
| <0.001 | Esophageal Neoplasms | NA | BeFree | Detail | |
| 0.002 | Fetal Diseases | NA | GAD | Detail | |
| 0.002 | Fetal Membranes, Premature Rupture | NA | GAD | Detail | |
| 0.002 | Gastrointestinal Diseases | NA | GAD | Detail | |
| <0.001 | glioblastoma | NA | BeFree | Detail | |
| <0.001 | Glioma | NA | BeFree | Detail | |
| 0.008 | Graft-vs-Host Disease | NA | GAD,LHGDN | Detail | |
| <0.001 | Graves Disease | NA | BeFree | Detail | |
| 0.003 | Hay fever | NA | LHGDN | Detail | |
| <0.001 | Atrial Septal Defects | Results herein suggest that HLA-G polymorphisms are associated with ASD developm... | BeFree | 25451607 | Detail |
| 0.003 | hepatitis | NA | BeFree,GAD | Detail | |
| <0.001 | hepatitis A | NA | BeFree | Detail | |
| <0.001 | hepatitis B | NA | BeFree | Detail | |
| <0.001 | Hepatitis, Chronic | NA | BeFree | Detail | |
| 0.003 | hepatitis C | NA | BeFree,GAD | Detail | |
| 0.024 | HIV Infections | Maternal human leukocyte antigen-G (HLA-G) genetic variants associate with in ut... | BeFree,GAD,LHGDN | 25541520 | Detail |
| 0.024 | HIV Infections | In this study, we conducted an extensive analysis of CD8(+) T cell responses res... | BeFree,GAD,LHGDN | 25911754 | Detail |
| 0.003 | Hodgkin Disease | NA | LHGDN | Detail | |
| 0.002 | Immediate hypersensitivity | NA | GAD | Detail | |
| 0.003 | Inflammatory Bowel Diseases | NA | BeFree,LHGDN | Detail | |
| <0.001 | Kidney Failure, Chronic | HLA-G gene expression influenced at allelic level in association with end stage ... | BeFree | 24929145 | Detail |
| 0.002 | Premature Obstetric Labor | NA | GAD | Detail | |
| <0.001 | Lentigo | NA | BeFree | Detail | |
| 0.004 | leukemia | NA | BeFree,LHGDN | Detail | |
| 0.003 | Acute Erythroblastic Leukemia | NA | LHGDN | Detail | |
| 0.003 | Leukemia, Myelocytic, Acute | NA | BeFree,LHGDN | Detail | |
| <0.001 | Leukemia, T-Cell | NA | BeFree | Detail | |
| 0.003 | Lung Neoplasms | NA | LHGDN | Detail | |
| 0.012 | Lupus Erythematosus, Systemic | Meta-analysis of the relationship between 14bp insertion/deletion polymorphism o... | BeFree,GAD,LHGDN | 25454623 | Detail |
| 0.004 | lymphoma | NA | BeFree,LHGDN | Detail | |
| 0.003 | Lymphoma, Non-Hodgkin | NA | LHGDN | Detail | |
| <0.001 | malaria | Innovative research examining the effect of PAM on the neurocognitive developmen... | BeFree | 25015559 | Detail |
| <0.001 | Malignant neoplasm of stomach | Significant HOTAIR overexpression was observed in GC tissues, as well as strong ... | BeFree | 26187665 | Detail |
| 0.010 | melanoma | NA | BeFree,LHGDN | Detail | |
| <0.001 | meningitis | NA | BeFree | Detail | |
| <0.001 | mitral valve stenosis | NA | BeFree | Detail | |
| 0.005 | Mucocutaneous Lymph Node Syndrome | NA | BeFree,GAD,LHGDN | Detail | |
| 0.004 | multiple myeloma | Furthermore, we found that the blocking of membrane-bound HLA class I rather tha... | BeFree,LHGDN | 24850305 | Detail |
| 0.016 | multiple sclerosis | NA | BeFree,GAD,LHGDN | Detail | |
| <0.001 | myasthenia gravis | NA | BeFree | Detail | |
| <0.001 | myositis | NA | BeFree | Detail | |
| <0.001 | Neoplasm Metastasis | NA | BeFree | Detail | |
| 0.003 | neuroblastoma | NA | BeFree,LHGDN | Detail | |
| 0.002 | ovarian carcinoma | NA | BeFree | Detail | |
| 0.003 | pemphigus | NA | LHGDN | Detail | |
| <0.001 | peritonitis | NA | BeFree | Detail | |
| 0.002 | Photosensitivity Disorders | NA | GAD | Detail | |
| 0.002 | pneumonia | NA | GAD | Detail | |
| <0.001 | polycythemia vera | NA | BeFree | Detail | |
| 0.022 | pre-eclampsia | NA | GAD,LHGDN | Detail | |
| 0.004 | Pregnancy Complications | Studies have linked HLA-G polymorphisms to pregnancy complications such as preec... | BeFree,GAD | 25637667 | Detail |
| <0.001 | ectopic pregnancy | NA | BeFree | Detail | |
| 0.002 | Prenatal Exposure Delayed Effects | NA | GAD | Detail | |
| 0.005 | psoriasis | NA | GAD,LHGDN | Detail | |
| 0.003 | rhinitis | NA | LHGDN | Detail | |
| 0.006 | sarcoidosis | NA | BeFree,GAD,LHGDN | Detail | |
| <0.001 | systemic scleroderma | The aim of this study was to evaluate HLA-G serum expression (sHLA-G) and the HL... | BeFree | 25847615 | Detail |
| 0.003 | Dermatologic disorders | NA | LHGDN | Detail | |
| 0.005 | Skin Neoplasms | NA | LHGDN | Detail | |
| 0.002 | thalassemia | NA | GAD | Detail | |
| 0.002 | Tobacco use disorder | NA | GAD | Detail | |
| <0.001 | African Trypanosomiasis | NA | BeFree | Detail | |
| 0.002 | Virus Diseases | Taken together, our results supported a role of the HLA-G 3' UTR polymorphisms a... | BeFree | 24758208 | Detail |
| 0.002 | Virus Diseases | Our observations suggest HLA-G as a mechanism to create a protected niche for th... | BeFree | 26195547 | Detail |
| <0.001 | B-Cell Lymphomas | NA | BeFree | Detail | |
| <0.001 | High Grade Lymphoma (neoplasm) | NA | BeFree | Detail | |
| <0.001 | diffuse large B-cell lymphoma | The potential influence of HLA-G polymorphisms on the susceptibility to DLBCL th... | BeFree | 25620080 | Detail |
| <0.001 | T-Cell Lymphoma | NA | BeFree | Detail | |
| 0.003 | Bronchial Hyperreactivity | NA | BeFree,GAD | Detail | |
| <0.001 | gestational diabetes | NA | BeFree | Detail | |
| <0.001 | Polyendocrinopathies, Autoimmune | NA | BeFree | Detail | |
| <0.001 | acute leukemia | NA | BeFree | Detail | |
| 0.002 | Premature Birth | NA | GAD | Detail | |
| <0.001 | esophageal carcinoma | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of testis | NA | BeFree | Detail | |
| <0.001 | Secondary malignant neoplasm of skin | NA | BeFree | Detail | |
| <0.001 | Autoimmune thyroid disease | NA | BeFree | Detail | |
| 0.002 | Tumor Progression | NA | BeFree | Detail | |
| <0.001 | teratocarcinoma | NA | BeFree | Detail | |
| <0.001 | Carcinoma, Large Cell | NA | BeFree | Detail | |
| 0.002 | Cervical Intraepithelial Neoplasia | NA | GAD | Detail | |
| <0.001 | uveal melanoma | NA | BeFree | Detail | |
| <0.001 | Malignant ascites | NA | BeFree | Detail | |
| 0.002 | Cancer of Nasopharynx | NA | GAD | Detail | |
| <0.001 | Papillary thyroid carcinoma | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of lung | NA | BeFree | Detail | |
| <0.001 | Asymptomatic Infections | NA | BeFree | Detail | |
| <0.001 | Coinfection | NA | BeFree | Detail | |
| <0.001 | Carcinoma breast stage IV | NA | BeFree | Detail | |
| <0.001 | cervical squamous cell carcinoma | NA | BeFree | Detail | |
| <0.001 | Conventional (Clear Cell) Renal Cell Carcinoma | NA | BeFree | Detail | |
| <0.001 | Solid tumour | NA | BeFree | Detail | |
| 0.001 | cervix carcinoma | NA | BeFree | Detail | |
| <0.001 | Squamous intraepithelial lesion | NA | BeFree | Detail | |
| <0.001 | multinodular goiter | NA | BeFree | Detail | |
| <0.001 | Human papilloma virus infection | HLA-G 3' untranslated region polymorphisms influence the susceptibility for huma... | BeFree | 24758208 | Detail |
| <0.001 | malignant mesothelioma | NA | BeFree | Detail | |
| <0.001 | Hematologic Neoplasms | NA | BeFree | Detail | |
| 0.002 | Immune thrombocytopenic purpura | NA | GAD | Detail | |
| <0.001 | Chronic small plaque psoriasis | We retrospectively analyzed the HLA-G 14-bp INS/DEL polymorphism of HLA-G gene i... | BeFree | 24909182 | Detail |
| <0.001 | Primary antiphospholipid syndrome | NA | BeFree | Detail | |
| <0.001 | Pervasive Development Disorder | An HLA-G(∗)14bp insertion/deletion polymorphism associates with the development ... | BeFree | 25451607 | Detail |
| <0.001 | Malignant neoplasm of esophagus | NA | BeFree | Detail | |
| <0.001 | Carcinogenesis | NA | BeFree | Detail | |
| 0.001 | Epithelial ovarian cancer | NA | BeFree | Detail | |
| <0.001 | invasive cancer | NA | BeFree | Detail | |
| <0.001 | Progressive Neoplastic Disease | The above findings indicate that the genetic 14-bp Del/Ins polymorphism in exon ... | BeFree | 25577194 | Detail |
| 0.002 | breast carcinoma | NA | BeFree | Detail | |
| <0.001 | polycythemia vera | HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F de... | BeFree | 18059484 | Detail |
| <0.001 | Carcinoma of lung | NA | BeFree | Detail | |
| 0.014 | Pregnancy loss | NA | GAD | Detail | |
| <0.001 | colon carcinoma | NA | BeFree | Detail | |
| <0.001 | stomach carcinoma | Significant HOTAIR overexpression was observed in GC tissues, as well as strong ... | BeFree | 26187665 | Detail |
| <0.001 | Carcinoma of bladder | NA | BeFree | Detail | |
| <0.001 | Central neuroblastoma | NA | BeFree | Detail | |
| 0.002 | Drug-Induced Liver Injury | NA | GAD | Detail | |
| <0.001 | Chronic graft-versus-host disease | NA | BeFree | Detail | |
| 0.008 | ovarian neoplasm | NA | BeFree,LHGDN | Detail | |
| 0.002 | Papillomavirus Infections | NA | GAD | Detail | |
| 0.001 | Malignant neoplasm of ovary | NA | BeFree | Detail | |
| <0.001 | Ductal Carcinoma | NA | BeFree | Detail | |
| <0.001 | Segmental vitiligo | Association between an HLA-G 14 bp insertion/deletion polymorphism and non-segme... | BeFree | 24639245 | Detail |
| <0.001 | Cutaneous lymphoma | NA | BeFree | Detail | |
| <0.001 | Infiltrating Cervical Carcinoma | NA | BeFree | Detail | |
| <0.001 | Epithelioma | NA | BeFree | Detail | |
| <0.001 | renal carcinoma | NA | BeFree | Detail | |
| <0.001 | Mammary Neoplasms | NA | BeFree | Detail | |
| <0.001 | Tumor Expansion | NA | BeFree | Detail | |
| <0.001 | Tumor Immunity | Human leukocyte antigen-E (HLA-E) is a nonclassical HLA class I molecule that ca... | BeFree | 25413103 | Detail |
| 0.001 | colorectal cancer | Kaplan-Meier analysis results showed that the expression levels of HLA-G or HLA-... | BeFree | 25461612 | Detail |
| <0.001 | Glioblastoma multiforme | NA | BeFree | Detail | |
| 0.001 | liver carcinoma | NA | BeFree | Detail | |
| <0.001 | Chronic kidney disease stage 5 | HLA-G gene expression influenced at allelic level in association with end stage ... | BeFree | 24929145 | Detail |
| <0.001 | IMMUNE SUPPRESSION | HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to ge... | BeFree | 24362551 | Detail |
| 0.010 | chronic lymphocytic leukemia | HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to ge... | BeFree | 24362551 | Detail |
| 0.002 | Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified | NA | GAD | Detail | |
| 0.003 | Prostatic Hyperplasia | NA | LHGDN | Detail | |
| 0.005 | Juvenile arthritis | NA | BeFree,GAD,LHGDN | Detail | |
| <0.001 | Progressive cGVHD | The above findings indicate that the genetic 14-bp Del/Ins polymorphism in exon ... | BeFree | 25577194 | Detail |
| 0.011 | Infection | NA | GAD,LHGDN | Detail | |
| 0.015 | Spontaneous abortion | NA | GAD,LHGDN | Detail | |
| 0.007 | Abortion, Habitual | NA | GAD,LHGDN | Detail | |
| 0.003 | adenocarcinoma | NA | LHGDN | Detail | |
| 0.003 | Anemia, Sickle Cell | NA | BeFree,GAD | Detail | |
| 0.003 | Anoxia | NA | LHGDN | Detail | |
| 0.009 | rheumatoid arthritis | HLA-G gene polymorphisms associated with susceptibility to rheumatoid arthritis ... | BeFree,GAD,LHGDN | 24957665 | Detail |
| 0.009 | rheumatoid arthritis | The study was conducted to investigate the frequency of three gene polymorphisms... | BeFree,GAD,LHGDN | 25656292 | Detail |
| 0.130 | asthma | A polymorphism in HLA-G modifies statin benefit in asthma. | BeFree,CTD_human,GAD,LHGDN | 25266681 | Detail |
| <0.001 | Astrocytoma | NA | BeFree | Detail | |
| 0.005 | Autoimmune Diseases | Several recent studies have provided evidence that a 14 bp insertion (INS)/delet... | BeFree,GAD | 24639245 | Detail |
| 0.008 | Behcet Syndrome | NA | BeFree,GAD,LHGDN | Detail | |
| <0.001 | Benign Ovarian Neoplasm | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of urinary bladder | NA | BeFree | Detail | |
| 0.005 | Bladder Neoplasm | NA | GAD,LHGDN | Detail | |
| <0.001 | Brain Neoplasms | NA | BeFree | Detail | |
| 0.002 | Malignant neoplasm of breast | NA | BeFree | Detail | |
| <0.001 | Malignant tumor of colon | NA | BeFree | Detail | |
| 0.014 | renal cell carcinoma | NA | BeFree,LHGDN | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Four SNPs (rs17875380, rs41557518, rs114465251, and rs115492845) were associated with altered suscep... | DisGeNET | Detail |
| Four SNPs (rs17875380, rs41557518, rs114465251, and rs115492845) were associated with altered suscep... | DisGeNET | Detail |
| HLA-G and susceptibility to develop celiac disease. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| If a fetus were aneuploid, attributing causation to a HLA-G 5'-URR SNP would be illogical; therefore... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Kaplan-Meier analysis results showed that the expression levels of HLA-G or HLA-E alone and the comb... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Association between sHLA-G and HLA-G 14-bp deletion/insertion polymorphism in Crohn's disease. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Results herein suggest that HLA-G polymorphisms are associated with ASD development, possibly as a c... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Maternal human leukocyte antigen-G (HLA-G) genetic variants associate with in utero mother-to-child ... | DisGeNET | Detail |
| In this study, we conducted an extensive analysis of CD8(+) T cell responses restricted by a single ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| HLA-G gene expression influenced at allelic level in association with end stage renal disease and ac... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Meta-analysis of the relationship between 14bp insertion/deletion polymorphism of HLA-G gene and sus... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Innovative research examining the effect of PAM on the neurocognitive development of the infant, as ... | DisGeNET | Detail |
| Significant HOTAIR overexpression was observed in GC tissues, as well as strong positive correlation... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Furthermore, we found that the blocking of membrane-bound HLA class I rather than HLA-G using antibo... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Studies have linked HLA-G polymorphisms to pregnancy complications such as preeclampsia and recurren... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The aim of this study was to evaluate HLA-G serum expression (sHLA-G) and the HLA-G gene 14 base pai... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Taken together, our results supported a role of the HLA-G 3' UTR polymorphisms as a susceptible fact... | DisGeNET | Detail |
| Our observations suggest HLA-G as a mechanism to create a protected niche for the bacterial reservoi... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The potential influence of HLA-G polymorphisms on the susceptibility to DLBCL thus deserves further ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| HLA-G 3' untranslated region polymorphisms influence the susceptibility for human papillomavirus inf... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We retrospectively analyzed the HLA-G 14-bp INS/DEL polymorphism of HLA-G gene in patients with mode... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| An HLA-G(∗)14bp insertion/deletion polymorphism associates with the development of autistic spectrum... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The above findings indicate that the genetic 14-bp Del/Ins polymorphism in exon 8 of the HLA-G gene ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: cli... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Significant HOTAIR overexpression was observed in GC tissues, as well as strong positive correlation... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Association between an HLA-G 14 bp insertion/deletion polymorphism and non-segmental vitiligo in the... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Human leukocyte antigen-E (HLA-E) is a nonclassical HLA class I molecule that canonically binds pept... | DisGeNET | Detail |
| Kaplan-Meier analysis results showed that the expression levels of HLA-G or HLA-E alone and the comb... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| HLA-G gene expression influenced at allelic level in association with end stage renal disease and ac... | DisGeNET | Detail |
| HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppre... | DisGeNET | Detail |
| HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppre... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The above findings indicate that the genetic 14-bp Del/Ins polymorphism in exon 8 of the HLA-G gene ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| HLA-G gene polymorphisms associated with susceptibility to rheumatoid arthritis disease and its seve... | DisGeNET | Detail |
| The study was conducted to investigate the frequency of three gene polymorphisms in the 3'-untransla... | DisGeNET | Detail |
| A polymorphism in HLA-G modifies statin benefit in asthma. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Several recent studies have provided evidence that a 14 bp insertion (INS)/deletion (DEL) polymorphi... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs114465251 dbSNP
- Genome
- hg19
- Position
- chr6:29,794,744-29,798,902
- Variant Type
- snv
Genome browser